AIM: To investigate the effect of early surgical intervention on the high surgical risk elderly patients who sustained femoral neck fracture (FNF) and taking concomitant antiplatelet agents. METHODS: Between 2010 and 2012, a prospective study was conducted on 49 geriatric patients, who took antiplatelet agents, sustained FNF and underwent surgery within 72 h [early surgery (ES) group], and these were compared with a retrospective consecutive case series of patients with similar characteristics (45 cases) who had delayed surgery (DS group) after 72 h during an earlier 3-year period. Postoperative outcomes were followed for one year and compared. RESULTS: There were non-significant differences in perioperative blood loss, blood transfusion, intensive care unit requirement and postoperative mortality (P > 0.05 all). There were 2 patients (4%) in the DS group who died after surgery (P = 0.23). However, the ES group showed a significantly better postoperative outcome in terms of postoperative complications, length of hospital stay, and functional outcome (P < 0.05 all). CONCLUSION: Early hip surgery in geriatric hip fracture patients with ongoing antiplatelet treatment was not associated with a significant increase of perioperative blood loss and postoperative mortality. Moreover, ES resulted in a better postoperative surgical outcome. In early hip surgery protocol, the antiplatelet agents are discontinued and the patient is operated on within 72 h after admission, which is safe and effective for the medically fit patients.
AIM: To investigate the effect of early surgical intervention on the high surgical risk elderly patients who sustained femoral neck fracture (FNF) and taking concomitant antiplatelet agents. METHODS: Between 2010 and 2012, a prospective study was conducted on 49 geriatric patients, who took antiplatelet agents, sustained FNF and underwent surgery within 72 h [early surgery (ES) group], and these were compared with a retrospective consecutive case series of patients with similar characteristics (45 cases) who had delayed surgery (DS group) after 72 h during an earlier 3-year period. Postoperative outcomes were followed for one year and compared. RESULTS: There were non-significant differences in perioperative blood loss, blood transfusion, intensive care unit requirement and postoperative mortality (P > 0.05 all). There were 2 patients (4%) in the DS group who died after surgery (P = 0.23). However, the ES group showed a significantly better postoperative outcome in terms of postoperative complications, length of hospital stay, and functional outcome (P < 0.05 all). CONCLUSION: Early hip surgery in geriatric hip fracturepatients with ongoing antiplatelet treatment was not associated with a significant increase of perioperative blood loss and postoperative mortality. Moreover, ES resulted in a better postoperative surgical outcome. In early hip surgery protocol, the antiplatelet agents are discontinued and the patient is operated on within 72 h after admission, which is safe and effective for the medically fit patients.
Entities:
Keywords:
Antiplatelet agents; Blood loss; Displaced femoral neck fracture; Early hip surgery; Elderly hip fracture; Hip arthroplasty
Authors: Valerie A Lawrence; Jeffrey H Silverstein; John E Cornell; Thomas Pederson; Helaine Noveck; Jeffrey L Carson Journal: Transfusion Date: 2003-12 Impact factor: 3.157
Authors: Matthew J Price; Jacqueline L Coleman; Steven R Steinhubl; Garrett B Wong; Christopher P Cannon; Paul S Teirstein Journal: Am J Cardiol Date: 2006-07-07 Impact factor: 2.778
Authors: Sarah K Westbury; Kate Downes; Claire Burney; Maria L Lozano; Samya G Obaji; Cheng Hock Toh; Teresa Sevivas; Neil V Morgan; Wendy N Erber; Carly Kempster; Samantha F Moore; Chantal Thys; Sofia Papadia; Willem H Ouwehand; Michael A Laffan; Keith Gomez; Kathleen Freson; Jose Rivera; Andrew D Mumford Journal: Blood Adv Date: 2018-09-25